Request an Appointment
Share Share to Facebook Share to Twitter Share via Email Print This Page More...

Research Division

 
Transforming Science into Improved Patient Care

Research at Hospital for Special Surgery is focused on identifying mechanisms underlying musculoskeletal and autoimmune conditions, and discovering and developing effective approaches for prevention, diagnosis, and treatment of orthopedic and rheumatic diseases.

  • More than 200 scientists and staff work on bench-to-bedside research on tissue degeneration, autoimmunity, biomechanics, bone biology, and tissue repair.  
  • Research is supported by more than $30 million annually in funding from the National Institutes of Health, foundations, industry, and philanthropy.
  • Multidisciplinary teams of basic scientists, biomedical engineers, and clinical investigators collaborate to define mechanisms involved in osteoarthritis, cartilage repair, lupus, and bone injury and regeneration.
  • More than 30 registries spanning orthopaedic and rheumatologic conditions collect data on patient demographics, disease and surgery details, and treatment and clinical outcomes on the more than 24,000 surgeries and 265,000 patient visits each year.
 

 


View and download the interactive
2011-2012 HSS Orthopaedic Research Report

Highlights

Mary Goldring, PhD was elected fourth Vice President of the Orthopaedic Research Society. The announcement, at the 56th Annual Meeting of the Orthopaedic Research Society, confirms Dr. Goldring’s path toward assuming the presidency in five years. Learn more

Registries provide the foundation for clinical trials, translational research, and treatment innovation. HSS has created more than 30 registries including the Hip, Knee and Shoulder Arthroplasty Registries, Sports Medicine and Shoulder Services ACL Registry, Center for Hip Preservation Registry, Autoimmune Disease Registry, and Scleroderma Registry. Read more and learn how to participate

Jane Salmon, MD is Principal Investigator on a multi-center NIH-funded research initiative, the PROMISSE study, to identify predictors of poor pregnancy outcomes in women with systemic lupus erythematosus (SLE). The study is providing insights on the genes and cellular pathways that can affect pregnancy in lupus patients and, potentially, cause miscarriage and preeclampsia in healthy women. Learn more

 
Share
Share to Facebook Share to Twitter Share via Email Print This Page More...